%0 Journal Article %J Ann Intern Med %D 2011 %T Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study. %A Mozaffarian, Dariush %A Lemaitre, Rozenn N %A King, Irena B %A Song, Xiaoling %A Spiegelman, Donna %A Sacks, Frank M %A Rimm, Eric B %A Siscovick, David S %K Aged %K Biomarkers %K Docosahexaenoic Acids %K Eicosapentaenoic Acid %K Fatty Acids, Omega-3 %K Fatty Acids, Unsaturated %K Feeding Behavior %K Heart Failure %K Humans %K Incidence %K Proportional Hazards Models %K Prospective Studies %K Risk Factors %X

BACKGROUND: Few previous studies have evaluated associations between long-chain ω-3 fatty acids and incidence of congestive heart failure (CHF), and those that have are typically based on diet questionnaires and yield conflicting results. Circulating fatty acid concentrations provide objective biomarkers of exposure.

OBJECTIVE: To determine whether plasma phospholipid concentrations of long-chain ω-3 fatty acids, including eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA), were associated with incident CHF.

DESIGN: Prospective cohort study.

SETTING: 4 U.S. communities.

PATIENTS: 2735 U.S. adults without prevalent heart disease who were enrolled in the Cardiovascular Health Study from 1992 to 2006.

MEASUREMENTS: Plasma phospholipid fatty acid concentrations and other cardiovascular risk factors were measured in 1992 by using standardized methods. Relationships with incident CHF (555 cases during 26 490 person-years, adjudicated by using medical records) were assessed by using Cox proportional hazards models.

RESULTS: After multivariate adjustment, plasma phospholipid EPA concentration was inversely associated with incident CHF; risk was approximately 50% lower in the highest versus the lowest quartile (hazard ratio [HR], 0.52 [95% CI, 0.38 to 0.72]; P for trend = 0.001). In similar analyses, trends toward lower risk were seen for DPA (HR, 0.76 [CI, 0.56 to 1.04]; P for trend = 0.057) and total long-chain ω-3 fatty acids (HR, 0.70 [CI, 0.49 to 0.99]; P for trend = 0.062) but not for DHA (HR, 0.84 [CI, 0.58 to 1.21]; P for trend = 0.38). In analyses censored to the middle of follow-up (7 years) to minimize exposure misclassification over time, multivariate-adjusted HRs were 0.48 for EPA (CI, 0.32 to 0.71; P for trend = 0.005), 0.61 for DPA (CI, 0.39 to 0.95; P for trend = 0.033), 0.64 for DHA (CI, 0.40 to 1.04; P for trend = 0.057), and 0.51 for total ω-3 fatty acids (CI, 0.32 to 0.80; P for trend = 0.003).

LIMITATIONS: Temporal changes in fatty acid concentrations over time may have caused underestimation of associations. Unmeasured or imperfectly measured covariates may have caused residual confounding.

CONCLUSION: Circulating individual and total ω-3 fatty acid concentrations are associated with lower incidence of CHF in older adults.

PRIMARY FUNDING SOURCE: National Institutes of Health.

%B Ann Intern Med %V 155 %P 160-70 %8 2011 Aug 02 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/21810709?dopt=Abstract %R 10.7326/0003-4819-155-3-201108020-00006 %0 Journal Article %J Am J Clin Nutr %D 2011 %T Fatty acids in the de novo lipogenesis pathway and risk of coronary heart disease: the Cardiovascular Health Study. %A Wu, Jason H Y %A Lemaitre, Rozenn N %A Imamura, Fumiaki %A King, Irena B %A Song, Xiaoling %A Spiegelman, Donna %A Siscovick, David S %A Mozaffarian, Dariush %K Aged %K Aged, 80 and over %K Cohort Studies %K Coronary Disease %K Death, Sudden, Cardiac %K Diet %K Fatty Acids %K Female %K Humans %K Lipogenesis %K Male %K Phospholipids %K Proportional Hazards Models %K Prospective Studies %K Risk Factors %X

BACKGROUND: De novo lipogenesis (DNL) is an endogenous pathway whereby carbohydrates and proteins are converted to fatty acids. DNL could affect coronary heart disease (CHD) or sudden cardiac arrest (SCA) via generation of specific fatty acids. Whether these fatty acids are prospectively associated with SCA or other CHD events is unknown.

OBJECTIVE: The objective was to investigate the relations of 4 fatty acids in the DNL pathway-palmitic acid (16:0), palmitoleic acid (16:1n-7), 7-hexadecenoic acid (16:1n-9), and cis-vaccenic acid (18:1n-7)-with incident CHD, including fatal CHD, nonfatal myocardial infarction (NFMI), and SCA.

DESIGN: A community-based prospective study was conducted in 2890 men and women aged ≥65 y, who were free of known CHD at baseline and who were followed from 1992 to 2006. Cardiovascular disease risk factors and plasma phospholipid fatty acids were measured at baseline by using standardized methods. Incident CHD was ascertained prospectively and was centrally adjudicated by using medical records. Risk was assessed by using multivariable-adjusted Cox proportional hazards.

RESULTS: During 29,835 person-years of follow-up, 631 CHD and 71 SCA events occurred. Both 18:1n-7 and 16:1n-9 were associated with a higher risk of SCA [multivariable-adjusted hazard ratio (95% CI) for the interquintile range: 7.63 (2.58, 22.6) for 18:1n-7 and 2.30 (1.16, 4.55) for 16:1n-9] but not of total CHD, fatal CHD, or NFMI. In secondary analyses censored to mid-follow-up (7 y) to minimize the effects of changes in concentrations over time, 16:1n-9 was also associated with a significantly higher risk of total CHD (2.11; 1.76, 2.54), including a higher risk of CHD death, NFMI, and SCA; 16:0 and 16:1n-7 were not associated with clinical CHD outcomes.

CONCLUSION: Higher plasma phospholipid 18:1n-7 and 16:1n-9 concentrations were prospectively associated with an elevated risk of SCA but not of other CHD events, except in secondary analyses.

%B Am J Clin Nutr %V 94 %P 431-8 %8 2011 Aug %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/21697077?dopt=Abstract %R 10.3945/ajcn.111.012054 %0 Journal Article %J Am J Clin Nutr %D 2012 %T Circulating and dietary α-linolenic acid and incidence of congestive heart failure in older adults: the Cardiovascular Health Study. %A Lemaitre, Rozenn N %A Sitlani, Colleen %A Song, Xiaoling %A King, Irena B %A McKnight, Barbara %A Spiegelman, Donna %A Sacks, Frank M %A Djoussé, Luc %A Rimm, Eric B %A Siscovick, David S %A Mozaffarian, Dariush %K Aged %K Alcohol Drinking %K alpha-Linolenic Acid %K Biomarkers %K Body Mass Index %K Cardiovascular Diseases %K Diet %K Fatty Acid Desaturases %K Female %K Follow-Up Studies %K Heart Failure %K Humans %K Incidence %K Male %K Polymorphism, Single Nucleotide %K Prevalence %K Prospective Studies %K Risk Factors %K Smoking %K Surveys and Questionnaires %K United States %X

BACKGROUND: Few studies have evaluated the association between the n-3 fatty acid α-linolenic acid (ALA) and the incidence of congestive heart failure (CHF).

OBJECTIVE: We investigated whether plasma phospholipid concentrations and estimated dietary consumption of ALA are associated with incident CHF.

DESIGN: We used data from the Cardiovascular Health Study, a prospective cohort study of cardiovascular diseases among adults aged ≥65 y, from 4 US communities. A total of 2957 participants free of prevalent heart disease and with available fatty acid measurements were included in biomarker analyses (30,722 person-years and 686 incident CHF events). A total of 4432 participants free of prevalent heart disease were included in dietary analyses (52,609 person-years and 1072 events). We investigated the association of ALA with incident CHF by using Cox regression.

RESULTS: After adjustment for age, sex, race, education, smoking status, BMI, waist circumference, and alcohol consumption, plasma phospholipid ALA was not associated with incident CHF (HR for the highest compared with the lowest quartile: 0.97; 95% CI: 0.79, 1.21; P-trend = 0.85). Likewise, dietary ALA was not associated with incident CHF (adjusted HR for the highest compared with the lowest quartile: 0.96; 95% CI: 0.82, 1.20; P-trend = 0.97). We observed no association of biomarker or dietary ALA with nonvalvular CHF subtype. We also found little evidence of an association between ALA and CHF in subgroups based on age, sex, diabetes, fish consumption, BMI, or FADS2 genotype (rs1535).

CONCLUSION: ALA intake is not associated with incident CHF in older adults. This trial was registered at clinicaltrials.gov as NCT00005133.

%B Am J Clin Nutr %V 96 %P 269-74 %8 2012 Aug %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/22743310?dopt=Abstract %R 10.3945/ajcn.112.037960 %0 Journal Article %J J Am Heart Assoc %D 2013 %T Associations of plasma phospholipid and dietary alpha linolenic acid with incident atrial fibrillation in older adults: the Cardiovascular Health Study. %A Fretts, Amanda M %A Mozaffarian, Dariush %A Siscovick, David S %A Heckbert, Susan R %A McKnight, Barbara %A King, Irena B %A Rimm, Eric B %A Psaty, Bruce M %A Sacks, Frank M %A Song, Xiaoling %A Spiegelman, Donna %A Lemaitre, Rozenn N %K Age Factors %K Aged %K Aged, 80 and over %K alpha-Linolenic Acid %K Atrial Fibrillation %K Biomarkers %K Diet %K Female %K Humans %K Incidence %K Linear Models %K Longitudinal Studies %K Male %K Nutritional Status %K Phospholipids %K Proportional Hazards Models %K Prospective Studies %K Risk Assessment %K Risk Factors %K Time Factors %K United States %X

BACKGROUND: Few studies have examined the relationship of α-linolenic acid (ALA 18:3n-3), an intermediate-chain essential n-3 polyunsaturated fatty acid derived from plants and vegetable oils, with incident atrial fibrillation (AF).

METHODS AND RESULTS: The study population included participants from the Cardiovascular Health Study, a community-based longitudinal cohort of adults aged 65 or older, free of prevalent coronary heart disease and atrial fibrillation. We assessed the associations of plasma phospholipid and dietary ALA with incident AF using Cox regression. The biomarker analysis comprised a total of 2899 participants, and the dietary analysis comprised 4337 participants. We found no association of plasma phospholipid ALA and incident AF. Comparing each of the second, third, and fourth quartiles to the lowest quartile, the hazard ratios for AF were 1.11 (95% CI, 0.90 to 1.37), 1.09 (95% CI, 0.88 to 1.35), and 0.92 (95% CI, 0.74 to 1.15), after adjustment for age, sex, race, clinic, education, smoking, alcohol, body mass index, waist circumference, diabetes, heart failure, stroke, treated hypertension, and physical activity (P trend=0.48). When dietary ALA was considered the exposure of interest, results were similar.

CONCLUSIONS: Results from this prospective cohort study of older adults indicate no association of plasma phospholipid or dietary ALA and incident AF.

%B J Am Heart Assoc %V 2 %P e003814 %8 2013 Jan 31 %G eng %N 1 %1 http://www.ncbi.nlm.nih.gov/pubmed/23525429?dopt=Abstract %R 10.1161/JAHA.112.003814 %0 Journal Article %J J Am Heart Assoc %D 2013 %T Circulating omega-3 polyunsaturated fatty acids and subclinical brain abnormalities on MRI in older adults: the Cardiovascular Health Study. %A Virtanen, Jyrki K %A Siscovick, David S %A Lemaitre, Rozenn N %A Longstreth, William T %A Spiegelman, Donna %A Rimm, Eric B %A King, Irena B %A Mozaffarian, Dariush %K Aged %K Animals %K Biomarkers %K Brain %K Cross-Sectional Studies %K Fatty Acids, Omega-3 %K Female %K Fishes %K Humans %K Magnetic Resonance Imaging %K Male %K Prospective Studies %X

BACKGROUND: Consumption of tuna or other broiled or baked fish, but not fried fish, is associated with fewer subclinical brain abnormalities on magnetic resonance imaging (MRI). We investigated the association between plasma phospholipid omega-3 polyunsaturated fatty acids (PUFAs), objective biomarkers of exposure, and subclinical brain abnormalities on MRI.

METHODS AND RESULTS: In the community-based Cardiovascular Health Study, 3660 participants aged ≥ 65 underwent brain MRI in 1992-1994, and 2313 were rescanned 5 years later. MRIs were centrally read by neuroradiologists in a standardized, blinded manner. Participants with recognized transient ischemic attacks or stroke were excluded. Phospholipid PUFAs were measured in stored plasma collected in 1992-1993 and related to cross-sectional and longitudinal MRI findings. After multivariable adjustment, the odds ratio for having a prevalent subclinical infarct was 0.60 (95% CI, 0.44 to 0.82; P for trend = 0.001) in the highest versus lowest long-chain omega-3 PUFA quartile. Higher long-chain omega-3 PUFA content was also associated with better white matter grade, but not with sulcal or ventricular grades, markers of brain atrophy, or with incident subclinical infarcts. The phospholipid intermediate-chain omega-3 PUFA alpha-linolenic acid was associated only with modestly better sulcal and ventricular grades. However, this finding was not supported in the analyses with alpha-linolenic acid intake.

CONCLUSIONS: Among older adults, higher phospholipid long-chain omega-3 PUFA content was associated with lower prevalence of subclinical infarcts and better white matter grade on MRI. Our results support the beneficial effects of fish consumption, the major source of long-chain omega-3 PUFAs, on brain health in later life. The role of plant-derived alpha-linolenic acid in brain health requires further investigation.

%B J Am Heart Assoc %V 2 %P e000305 %8 2013 Oct 10 %G eng %N 5 %1 http://www.ncbi.nlm.nih.gov/pubmed/24113325?dopt=Abstract %R 10.1161/JAHA.113.000305 %0 Journal Article %J Br J Nutr %D 2014 %T Plasma phospholipid and dietary α-linolenic acid, mortality, CHD and stroke: the Cardiovascular Health Study. %A Fretts, Amanda M %A Mozaffarian, Dariush %A Siscovick, David S %A Sitlani, Colleen %A Psaty, Bruce M %A Rimm, Eric B %A Song, Xiaoling %A McKnight, Barbara %A Spiegelman, Donna %A King, Irena B %A Lemaitre, Rozenn N %K Aged %K alpha-Linolenic Acid %K Cardiovascular Diseases %K Cohort Studies %K Coronary Disease %K Diet %K Female %K Humans %K Male %K Mortality %K Phospholipids %K Proportional Hazards Models %K Prospective Studies %K Risk Factors %K Stroke %K United States %X

Previous studies have suggested that long-chain n-3 fatty acids derived from seafood are associated with a lower risk of mortality, CHD and stroke. Whether α-linolenic acid (ALA, 18 : 3n-3), a plant-derived long-chain essential n-3 fatty acid, is associated with a lower risk of these outcomes is unclear. The aim of the present study was to examine the associations of plasma phospholipid and dietary ALA with the risk of mortality, CHD and stroke among older adults who participated in the Cardiovascular Health Study, a cohort study of adults aged ≥ 65 years. A total of 2709 participants were included in the plasma phospholipid ALA analysis and 2583 participants were included in the dietary ALA analysis. Cox regression was used to assess the associations of plasma phospholipid and dietary ALA with the risk of mortality, incident CHD and stroke. In minimally and multivariable-adjusted models, plasma phospholipid ALA was found to be not associated with the risk of mortality, incident CHD or stroke. After adjustment for age, sex, race, enrolment site, education, smoking status, diabetes, BMI, alcohol consumption, treated hypertension and total energy intake, higher dietary ALA intake was found to be associated with a lower risk of total and non-cardiovascular mortality; on comparing the highest quintiles of dietary ALA with the lowest quintiles, the HR for total mortality and non-cardiovascular mortality were found to be 0·73 (95 % CI 0·61, 0·88) and 0·64 (95 % CI 0·52, 0·80), respectively. Dietary ALA was found to be not associated with the risk of cardiovascular mortality, incident CHD or stroke. In conclusion, the results of the present suggest study that dietary ALA, but not plasma phospholipid ALA, is associated with a lower risk of total and non-cardiovascular mortality in older adults.

%B Br J Nutr %V 112 %P 1206-13 %8 2014 Oct 14 %G eng %N 7 %1 http://www.ncbi.nlm.nih.gov/pubmed/25159901?dopt=Abstract %R 10.1017/S0007114514001925 %0 Journal Article %J J Am Heart Assoc %D 2014 %T Plasma phospholipid saturated fatty acids and incident atrial fibrillation: the Cardiovascular Health Study. %A Fretts, Amanda M %A Mozaffarian, Dariush %A Siscovick, David S %A Djoussé, Luc %A Heckbert, Susan R %A King, Irena B %A McKnight, Barbara %A Sitlani, Colleen %A Sacks, Frank M %A Song, Xiaoling %A Sotoodehnia, Nona %A Spiegelman, Donna %A Wallace, Erin R %A Lemaitre, Rozenn N %K Aged %K Aged, 80 and over %K Atrial Fibrillation %K Eicosanoic Acids %K Fatty Acids %K Female %K Humans %K Longitudinal Studies %K Male %K Palmitic Acid %K Phospholipids %K Proportional Hazards Models %K Prospective Studies %K Risk Factors %K Stearic Acids %K United States %X

BACKGROUND: Prior studies suggest that circulating fatty acids may influence the risk of atrial fibrillation (AF), but little is known about the associations of circulating saturated fatty acids with risk of AF.

METHODS AND RESULTS: The study population included 2899 participants from the Cardiovascular Health Study, a community-based longitudinal cohort of adults aged 65 years or older in the United States who were free of prevalent coronary heart disease and AF in 1992. Cox regression was used to assess the association of all the long-chain saturated fatty acids-palmitic acid (16:0), stearic acid (18:0), arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0)-with incident AF. During a median of 11.2 years of follow-up, 707 cases of incident AF occurred. After adjustment for other AF risk factors, higher levels of circulating 16:0 were associated with a higher risk of AF (hazard ratio comparing highest and lowest quartiles: 1.48; 95% CI: 1.18, 1.86). In contrast, higher levels of circulating 18:0, 20:0, 22:0, and 24:0 were each associated with a lower risk of AF. The hazard ratios (95% CI) for AF in the top and bottom quartiles were 0.76 (95% CI: 0.61, 0.95) for 18:0; 0.78 (95% CI: 0.63, 0.97) for 20:0; 0.62 (95% CI: 0.50, 0.78) for 22:0; and 0.68 (95% CI: 0.55, 0.85) for 24:0.

CONCLUSIONS: Results from this prospective cohort study of older adults demonstrate divergent associations of circulating 16:0 versus longer-chain saturated fatty acids with incident AF, highlighting the need to investigate both determinants of these levels and potential pathways of the observed differential risk.

%B J Am Heart Assoc %V 3 %P e000889 %8 2014 Jun 26 %G eng %N 3 %1 http://www.ncbi.nlm.nih.gov/pubmed/24970268?dopt=Abstract %R 10.1161/JAHA.114.000889 %0 Journal Article %J J Nutr %D 2016 %T Associations of Plasma Phospholipid SFAs with Total and Cause-Specific Mortality in Older Adults Differ According to SFA Chain Length. %A Fretts, Amanda M %A Mozaffarian, Dariush %A Siscovick, David S %A King, Irena B %A McKnight, Barbara %A Psaty, Bruce M %A Rimm, Eric B %A Sitlani, Colleen %A Sacks, Frank M %A Song, Xiaoling %A Sotoodehnia, Nona %A Spiegelman, Donna %A Lemaitre, Rozenn N %K Aged %K Aged, 80 and over %K Cause of Death %K Diet %K Dietary Fats %K Eicosanoic Acids %K Fatty Acids %K Female %K Humans %K Male %K Mortality %K Palmitic Acid %K Phospholipids %K Prospective Studies %K Risk Factors %K Stearic Acids %X

BACKGROUND: Not much is known about the relations of circulating saturated fatty acids (SFAs), which are influenced by both metabolic and dietary determinants, with total and cause-specific mortality.

OBJECTIVE: We examined the associations of plasma phospholipid SFAs with total and cause-specific mortality among 3941 older adults from the Cardiovascular Health Study, a population-based prospective study of adults aged ≥65 y who were followed from 1992 through 2011.

METHODS: The relations of total and cause-specific mortality with plasma phospholipid palmitic acid (16:0), stearic acid (18:0), arachidic acid (20:0), behenic acid (22:0), and lignoceric acid (24:0) were assessed using Cox proportional hazards models.

RESULTS: During 45,450 person-years of follow-up, 3134 deaths occurred. Higher concentrations of the plasma phospholipid SFAs 18:0, 22:0, and 24:0 were associated with a lower risk of total mortality [multivariable-adjusted HRs (95% CIs)] for the top compared with the bottom quintile: 0.85 (0.75, 0.95) for 18:0; 0.85 (0.75, 0.95) for 22:0; and 0.80 (0.71, 0.90) for 24:0. In contrast, plasma 16:0 concentrations in the highest quintile were associated with a higher risk of total mortality compared with concentrations in the lowest quintile [1.25 (1.11, 1.41)]. We also found no association of plasma phospholipid 20:0 with total mortality.

CONCLUSIONS: These findings suggest that the associations of plasma phospholipid SFAs with the risk of death differ according to SFA chain length and support future studies to better characterize the determinants of circulating SFAs and to explore the mechanisms underlying these relations.

%B J Nutr %V 146 %P 298-305 %8 2016 Feb %G eng %N 2 %1 http://www.ncbi.nlm.nih.gov/pubmed/26701797?dopt=Abstract %R 10.3945/jn.115.222117